Phase II Clinical Study of Radium-223 Chloride (BAY 88-8223) in Japanese Patients With Symptomatic Castration-Resistant Prostate Cancer (CRPC) With Bone Metastases

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2016年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [1] Phase II clinical study of radium-223 chloride (BAY 88-8223) in Japanese patients with symptomatic castration-resistant prostate cancer (CRPC) with bone metastases.
    Uemura, Hiroji
    Nagamori, Satoshi
    Wakumoto, Yoshiaki
    Uemura, Hirotsugu
    Kimura, Go
    Yokomizo, Akira
    Kikukawa, Hiroaki
    Mizokami, Atsushi
    Kosaka, Takeo
    Masumori, Naoya
    Kawasaki, Yoshihide
    Yonese, Junji
    Nasu, Yasutomo
    Fukasawa, Satoshi
    Sugiyama, Takayuki
    Uemura, Motohide
    Yamaguchi, Iku
    Tsutsui, Hirokazu
    Matsunaga, Eisuke
    Matsubara, Nobuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [2] Safety and efficacy of radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases
    Uemura, Hirotsugu
    Uemura, Hiroji
    Matsubara, N.
    Kaneko, M.
    Doi, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S489 - S489
  • [3] Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases
    Keisuke Yoshida
    Tomohiro Kaneta
    Shoko Takano
    Madoka Sugiura
    Tsuyoshi Kawano
    Ayako Hino
    Tou Yamamoto
    Kazuya Shizukuishi
    Masato Kaneko
    Christian Zurth
    Tomio Inoue
    Annals of Nuclear Medicine, 2016, 30 : 453 - 460
  • [4] Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases
    Yoshida, Keisuke
    Kaneta, Tomohiro
    Takano, Shoko
    Sugiura, Madoka
    Kawano, Tsuyoshi
    Hino, Ayako
    Yamamoto, Tou
    Shizukuishi, Kazuya
    Kaneko, Masato
    Zurth, Christian
    Inoue, Tomio
    ANNALS OF NUCLEAR MEDICINE, 2016, 30 (07) : 453 - 460
  • [5] Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
    Nobuaki Matsubara
    Satsohi Nagamori
    Yoshiaki Wakumoto
    Hirotsugu Uemura
    Go Kimura
    Akira Yokomizo
    Hiroaki Kikukawa
    Atsushi Mizokami
    Takeo Kosaka
    Naoya Masumori
    Yoshihide Kawasaki
    Junji Yonese
    Yasutomo Nasu
    Satoshi Fukasawa
    Takayuki Sugiyama
    Seigo Kinuya
    Makoto Hosono
    Iku Yamaguchi
    Hirokazu Tsutsui
    Hiroji Uemura
    International Journal of Clinical Oncology, 2018, 23 : 173 - 180
  • [6] Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
    Matsubara, Nobuaki
    Nagamori, Satsohi
    Wakumoto, Yoshiaki
    Uemura, Hirotsugu
    Kimura, Go
    Yokomizo, Akira
    Kikukawa, Hiroaki
    Mizokami, Atsushi
    Kosaka, Takeo
    Masumori, Naoya
    Kawasaki, Yoshihide
    Yonese, Junji
    Nasu, Yasutomo
    Fukasawa, Satoshi
    Sugiyama, Takayuki
    Kinuya, Seigo
    Hosono, Makoto
    Yamaguchi, Iku
    Tsutsui, Hirokazu
    Uemura, Hiroji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 173 - 180
  • [7] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
    Vogelzang, Nicholas J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
  • [8] Radium-223 chloride: Radiation safety, tolerability, and survival gain in patients with castration-resistant prostate cancer (CRPC) and bone metastases
    Lewington, Valerie
    Lamey, Roy
    Staudacher, Karin
    Vogelzang, Nicholas
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [9] Phase 3 study of radium-223 dichloride (Ra-223) in Asian patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets)
    Sun, Y.
    Shi, H.
    Chen, C. -H.
    Lee, J. L.
    Kang, T. W.
    Park, S. H.
    Wu, T. L.
    Ng, Q. S.
    Keam, B.
    Wong, S. C. A.
    Tay, M. H.
    Ding, Q.
    Li, F.
    Ng, D. C. E.
    Liu, X.
    Zhang, Z.
    Guo, J.
    ANNALS OF ONCOLOGY, 2015, 26 : 73 - 74
  • [10] Pharmacokinetics of single-does radium 223 dichloride (bay 88-8223) in japanese patients with castrate-resistant prostate cancer and bone metastases
    Yoshida, Keisuke
    Takano, Shoko
    Sugiura, Madoka
    Kawano, Tsuyoshi
    Hino, Ayako
    Yamamoto, Tou
    Shizukuishi, Kazuya
    Kaneko, Masato
    Zurth, Christian
    Inoue, Tomio
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
12345